Bivalent Vaccine against Streptococcus agalactiae and Aeromonas hydrophila in Nile Tilapia (Oreochromis niloticus): A Laboratory-Phase and Large-Scale Study.

Autor: Rivas, Açucena Veleh, dos Santos, Angelo Gabriel Vidal, de Souza, Adrieli Barboza, Bueno Junior, Gilson, de Souza, Gabriela Fernandes, de Souza, Estevam Martins, de Carvalho Nunes, Louisiane, Viana, Kelvinson Fernandes
Předmět:
Zdroj: Animals (2076-2615); Nov2023, Vol. 13 Issue 21, p3338, 12p
Abstrakt: Simple Summary: Vaccination can prevent infection by opportunistic bacteria that affect fish. We have developed and analyzed a bivalent vaccine against two of the main pathogens that affect fish. We found that the vaccine was safe and effective in laboratory tests and in large-scale tests, with better survival and feed conversion in immunized animals. These results indicate the need for field tests to confirm real protection. This developed vaccine could allow fish farmers greater protection for commercial fish production. One of the main factors limiting tilapia's production is the occurrence of infections caused by Aeromonas and Streptococcus species. This work intended to evaluate a bivalent vaccine against A. hydrophila and S. agalactiae by intraperitoneal (i.p) administration in Nile tilapia (Oreochromis niloticus) in Brazil. The study was carried out in two phases: one in the laboratory, on a small scale, and from the results obtained, the study was expanded to a large scale in a production system in cages. The vaccine proved to be safe and effective in laboratory tests, with a vaccine efficacy (VE) of 93.66%. However, in large-scale tests with 12,000 tilapias, the VE was 59.14%, with a better food conversion ratio (1.54 kg) in the vaccinated group compared to the control group (1.27 kg). These results corroborate the efficiency of this tested vaccine; however, they indicate the need for field tests to attest to real protection. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje